Price
No data yet.
Social Signal Score
Analyst Ratings
10 analystsRevenue
$56.01M+442.57%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Laura A. Francis
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 376
- Beta
- 0.70
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 6.29
Financials
Revenue
$56.01M+442.6%Net Income
$-4.09MEBITDA
$-3.13MFree Cash Flow
$-768.0KEPS (diluted)
$-0.09Shares Outstanding (diluted)
44.22M+1413.5%Operating Expenses
$49.35MCash & Debt
$145.94MReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $200.93M | $-18.91M | $-0.44 |
| 2024 | $167.18M | $-30.91M | $-0.75 |
| 2023 | $138.89M | $-43.34M | $-1.13 |
| 2022 | $106.41M | $-61.26M | $-1.79 |
| 2021 | $90.15M | $-56.57M | $-1.71 |
| 2020 | $73.39M | $-43.70M | $-1.50 |
| 2019 | $67.30M | $-38.40M | $-1.72 |
| 2018 | $55.38M | $-17.45M | $-1.10 |
| 2017 | $47.98M | $-23.04M | $-1.66 |
| 2016 | $42.10M | $-20.59M | $-1.33 |
| 2015 | $41.17M | $-28.15M | $-1.17 |
| 2014 | $40.05M | $-27.81M | $-10.42 |
| 2013 | $49.00M | $-6.15M | $-2.69 |
| 2012 | $37.02M | $-10.90M | $-5.76 |
Valuation
SIBNhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
120-4.00%Social Signal Score
Mentions (3)
- Newsseekingalpha.com·25d ago·Positive
SI-BONE, Inc. (SIBN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript SI-BONE, Inc. (SIBN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newszacks.com·45d ago·Positive
Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy? Does Si-Bone (SIBN) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newszacks.com·46d ago·Positive
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade The mean of analysts' price targets for Si-Bone (SIBN) points to a 25.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
View source ↗
Earnings
Mon, Nov 9(in 4 weeks)
Consensus estimate $-0.13 per share
Typical surprise +37.5% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Aug 3$-0.09 vs $-0.15beat
- Mon, May 11$-0.10 vs $-0.17beat
- Mon, Feb 23$-0.04 vs $-0.13beat
- Mon, Nov 10$-0.11 vs $-0.16beat
- Mon, Aug 4$-0.14 vs $-0.19beat
- Mon, May 5$-0.15 vs $-0.24beat
Estimates and results for SIBN via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by SIBN officers and directors.
- Bought
- —
- Sold
- $7.5m
0 trades
73 trades
- Dunn Jeffrey Wsold
- Dunn Jeffrey Wsold
- Dunn Jeffrey Wsold
- Francis Laurasold
- Maheshwari Anshulsold
- Francis Laurasold
- Maheshwari Anshulsold
- Francis Laurasold
27 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in SIBN.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.